Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Avexegen Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Avexegen Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
10210 Campus Point Dr, Suite 150 San Diego, CA 92121
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Avexegen will use the NIH funds to develop an orally efficacious, NRG-4-based drug product with localized action in the gut and a superior safety profile.


Lead Product(s): Neuregulin-4-based therapy

Therapeutic Area: Gastroenterology Product Name: Undisclosed

Highest Development Status: UndisclosedProduct Type: Peptide

Partner/Sponsor/Collaborator: National Institutes of Health

Deal Size: $3.0 million Upfront Cash: Undisclosed

Deal Type: Funding February 15, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY